Antihypertensive Drug Selection Based on Hemodynamic Phenotypes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 240 participants.
Also called NCT07240909
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 240 participants
- Registry
-
NCT07240909
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07240909. Randomized; single masking; primary purpose treatment. Start 2026-01 (anticipated); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Antihypertensive Drug Selection Based on Hemodynamic Phenotypes
- Acronym
- HEMOPHENO
- Condition
- Hypertension
- Intervention (Drug)
- hemodynamics-based individualized antihypertensive therapy
- Intervention (Drug)
- guideline-based conventional treatment
- Lead sponsor
- The Third Xiangya Hospital of Central South University
Record details
- Record id
cardio:ct-nct07240909- Content hash
679e7358f7d540cf24a92feb76c5780791e4c9f48f6bd675693b37bd0f3ac07d